Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Bayer : helping people affected by the earthquake in Mexico

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/03/2017 | 01:45pm CET

Release date- 29092017 - Leverkusen - As part of its disaster relief program, Bayer is donating medicines worth EUR 268,000 to the victims of the major earthquake that struck Mexico.

This aid will offer speedy and unbureaucratic relief to the people affected by this tragedy in Central America. The medicines will be sent to the non-profit organization Direct Relief for distribution to people injured in the quake. Direct Relief is a long-term strategic partner of Bayer that provides assistance and medical supplies around the world to regions torn by crisis and areas with limited medical access. Mexico City was hit by a magnitude 7.1 earthquake on September 19, 2017, and hundreds of people perished.

Providing disaster relief is part of Bayer's social commitment. The company follows a dual strategy to help people affected by acute hardship: When disaster strikes, Bayer provides immediate assistance - either by donating money and medicines or making material donations to help rebuild infrastructure. In addition, Bayer AG's charitable foundation, the Bayer Cares Foundation, supports long-term reconstruction projects.

In 2017, Bayer has already provided support to projects in the following nine regions affected by disasters: The Brazilian organization Mundo Positivo received a donation of EUR 203,000 to implement a preventive program in the state of Pernambuco, which has been hit by the Zika virus. The Canadian Red Cross received EUR 14,000 to combat devastating wildfires in rural areas. The organization Direct Relief and the American Red Cross received EUR 93,000 each to provide rapid assistance to people in the U.S. state of Texas, one of the areas hit by Hurricane Harvey. The Chilean fire service received EUR 92,000 to initiate a family protection program. Medicines were donated to the CDC Foundation for distribution to young women attending prenatal visits in Puerto Rico, one of the countries affected by the Zika virus (worth EUR 56,000); the Colombian Civil Air Patrol to assist people affected by flooding in Mocoa (EUR 24,000) and U.S. animal welfare organizations to help care for pets and livestock injured by Hurricane Harvey (EUR 24,000). The Nigerian Ministry of Agriculture also received plant protection products worth EUR 30,000 for smallholder farmers to use to treat crops infested with armyworm moths. In total, ten projects have now received donations of money or products totaling around EUR 897,000.

Bayer Cares Foundation

As the social welfare foundation of the innovation company Bayer, the Bayer Cares Foundation sees itself especially as an initiator, promoter and partner for innovation at the interface between industry and the social sector. The sponsorship programs are focused on people - their commitment to public welfare, their wealth of ideas in fulfilling social needs, as well as those that arise in times of emergency. The foundation's funding activities are a central element of Bayer's global social commitment amounting to approximately EUR 50 million annually - with the focus on promoting scientific education and leading-edge research, and on providing health care and meeting the basic social needs of people who live near the company's sites.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Contact:

Tel: +49 214 30-39239

Fax: +49 214 30-58923

Email: [email protected]

(c) 2017 Electronic News Publishing -, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
12:56a Monsanto offers cash to U.S. farmers who use controversial chemical
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 BAYER : Preventive Maintenance & service solution on existing Bayer/Medrad and A..
12/08 BAYER : J-- Preventive Maintenance & service solution on existing Bayer/Medrad a..
12/08 'Right steps' point to a healthier China
12/07 BAYER : Research Conducted at Bayer Has Provided New Information about Atrial Fi..
12/07 BAYER : Findings from Bayer Has Provided New Data on Liver Cancer (Exposure-resp..
12/07 BAYER : New Findings from Bayer in Antibiotics Provides New Insights (Physiologi..
12/07 BAYER : New Bayer transparency website launched
12/07 BAYER : Many disease-causing pathogens that are transferable from pets to humans..
More news
News from SeekingAlpha
12/08 BLOOMBERG : Bayer to face EU objections to Monsanto deal in coming days
12/07 COBAS ASSET MANAGEMENT : Comments On Third Quarter 2017
12/06 You Get A Dilution! You Get A Dilution! What About CRISPR Therapeutics?
12/05 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 5, 2017
12/02 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 2, 2017
Financials (€)
Sales 2017 35 698 M
EBIT 2017 7 647 M
Net income 2017 6 050 M
Debt 2017 8 890 M
Yield 2017 2,51%
P/E ratio 2017 13,79
P/E ratio 2018 18,04
EV / Sales 2017 2,67x
EV / Sales 2018 2,43x
Capitalization 86 581 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 121 €
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER5.77%101 894
JOHNSON & JOHNSON21.23%377 698
NOVARTIS11.34%218 728
PFIZER9.48%213 036
ROCHE HOLDING LTD.6.19%208 877
MERCK AND COMPANY-7.68%151 559